Analysis of psychological adverse reactions profile of the selective inibitors of the recaptation of serotonin (sirs) (2013)
- Authors:
- Autor USP: KANO, EUNICE KAZUE - FCF
- Unidade: FCF
- Subjects: SEROTONINA; SISTEMA NERVOSO CENTRAL
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 49, suppl. 3, p. 13 res. FCF021, 2013
- Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences
-
ABNT
PADILHA, Gabriel Felipe Silva e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Analysis of psychological adverse reactions profile of the selective inibitors of the recaptation of serotonin (sirs). Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 01 abr. 2026. , 2013 -
APA
Padilha, G. F. S., Ribeiro, A. G., & Kano, E. K. (2013). Analysis of psychological adverse reactions profile of the selective inibitors of the recaptation of serotonin (sirs). Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Padilha GFS, Ribeiro AG, Kano EK. Analysis of psychological adverse reactions profile of the selective inibitors of the recaptation of serotonin (sirs). Brazilian Journal of Pharmaceutical Sciences. 2013 ; 49 13 res. FCF021.[citado 2026 abr. 01 ] -
Vancouver
Padilha GFS, Ribeiro AG, Kano EK. Analysis of psychological adverse reactions profile of the selective inibitors of the recaptation of serotonin (sirs). Brazilian Journal of Pharmaceutical Sciences. 2013 ; 49 13 res. FCF021.[citado 2026 abr. 01 ] - Desenvolvimento e validação de método bioanalítico para quantificação de fluconazol em plasma humano
- Development and validation of a bioanalytical method for quantification of fluconazole in human plasma
- Cloxacillin benzathine-loaded polymeric nanocapsules: physicochemical characterization, cell uptake, and intramammary antimicrobial effect
- Adverse drug reactions related to use of interferon beta-1A, interferon beta-1B and glatiramer for multiple sclerosis treatment
- Atrioventricular block associated with the first dose of fingolimod
- Serious cardiovascular adverse drug reactions related to immunomodulators used in the treatment of multiple sclerosis
- Insulin Glargine and cancer incidence
- Rituximab and hematological adverse drug reaction in patients with rheumatoid arthritis
- Risk of pancreatic cancer associated with therapy based on incretins
- Serious adverse drug reaction of immunobiological drugs used in the treatment of psoriasis
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
